Vijay Karwal

Directeur/Membre du Conseil chez MEGA LIFESCIENCES

55 ans

Health Technology

Finance

Consumer Services

Profil

Mr. Vijay Karwal is an Independent Non-Executive Director at OneSource Specialty Pharma Ltd., an Independent Director at Mega Lifesciences Public Co. Ltd. and a Chief Financial Officer at AffaMed Therapeutics (HK) Ltd. He is on the Board of Directors at OneSource Specialty Pharma Ltd. and Mega Lifesciences Public Co. Ltd. Mr. Karwal was previously employed as a Managing Director by CBC Group (Singapore) Pte.
Ltd., an Operating Partner by Cbc Group Hk, a Managing Director by Nomura International (Hong Kong) Ltd., and a Chief Development Officer by Davita, Inc. (Singapore).
He received his graduate degree from the University of Groningen.

Postes actifs de Vijay Karwal

Sociétés	Poste	Début
MEGA LIFESCIENCES	Directeur/Membre du Conseil	13/05/2021
ONESOURCE SPECIALTY PHARMA LIMITED	Directeur/Membre du Conseil	27/02/2025
AffaMed Therapeutics (HK) Ltd. AffaMed Therapeutics (HK) Ltd. BiotechnologyHealth Technology Develops and commercializes ophthalmology, neurological and psychiatric products	Directeur Financier/CFO	01/05/2021

Tous les postes actifs de Vijay Karwal

Anciens postes connus de Vijay Karwal

Sociétés	Poste	Fin
Cbc Group Hk Cbc Group Hk Investment ManagersFinance Functions as an alternative investment manager	Private Equity Investor	01/04/2024
Nomura International (Hong Kong) Ltd. Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	01/05/2021
Davita, Inc. (Singapore)	Corporate Officer/Principal	01/11/2017
CBC Group (Singapore) Pte. Ltd. CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company.	Private Equity Investor	-

Voir l'expérience en détail de Vijay Karwal

Formation de Vijay Karwal

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Vijay Karwal

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	8
University of Groningen University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nomura International (Hong Kong) Ltd. Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services	Finance
Mega Lifesciences Public Co. Ltd. Mega Lifesciences Public Co. Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and trades health food supplements & pharmaceutical products	Health Technology
OneSource Specialty Pharma Ltd. OneSource Specialty Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures GLP-1 drugs & novel biologics	Health Technology
CBC Group (Singapore) Pte. Ltd. CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company.	Finance
AffaMed Therapeutics (HK) Ltd. AffaMed Therapeutics (HK) Ltd. BiotechnologyHealth Technology Develops and commercializes ophthalmology, neurological and psychiatric products	Health Technology
Davita, Inc. (Singapore)
Cbc Group Hk Cbc Group Hk Investment ManagersFinance Functions as an alternative investment manager	Finance